APA (7th ed.) Citation

D, S., AN, S., A, P., S, S., P, V., SM, N., . . . DP, K. (2023). AATF inhibition exerts antiangiogenic effects against human hepatocellular carcinoma. Frontiers in oncology, 13, 1130380. https://doi.org/10.3389/fonc.2023.1130380

Chicago Style (17th ed.) Citation

D, Suresh, Srinivas AN, Prashant A, Satish S, Vishwanath P, Nataraj SM, Koduru SV, Santhekadur PK, and Kumar DP. "AATF Inhibition Exerts Antiangiogenic Effects Against Human Hepatocellular Carcinoma." Frontiers in Oncology 13 (2023): 1130380. https://doi.org/10.3389/fonc.2023.1130380.

MLA (9th ed.) Citation

D, Suresh, et al. "AATF Inhibition Exerts Antiangiogenic Effects Against Human Hepatocellular Carcinoma." Frontiers in Oncology, vol. 13, 2023, p. 1130380, https://doi.org/10.3389/fonc.2023.1130380.

Warning: These citations may not always be 100% accurate.